Zota Health Care (NSE:ZOTA) Cyclically Adjusted Revenue per Share: ₹80.77 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ZOTA Zota Health Care Ltd NSE:ZOTA
79 GF Score
Price ₹1,252.50
GF Value ₹1,664.08
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Zota Health Care Cyclically Adjusted Revenue per Share?

Zota Health Care NSE:ZOTA -1.04% 79 Cyclically Adjusted Revenue per Share is ₹80.77 as of Mar. 2026. GuruFocus rates NSE:ZOTA with a GF Score™ of 79/100 and a GF Value™ of ₹1,664.08 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Zota Health Care's adjusted revenue per share for the three months ended in Mar. 2026 was ₹47.565. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹80.77 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-05), Zota Health Care's current stock price is ₹1252.50. Zota Health Care's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ₹80.77. Zota Health Care's Cyclically Adjusted PS Ratio of today is 15.51.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Zota Health Care was 17.89. The lowest was 13.75. And the median was 16.00.


Zota Health Care  (NSE:ZOTA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Zota Health Care's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1252.50/80.77
=15.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Zota Health Care was 17.89. The lowest was 13.75. And the median was 16.00.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Zota Health Care Cyclically Adjusted Revenue per Share Related Terms


Zota Health Care Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Zota Health Care's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zota Health Care Cyclically Adjusted Revenue per Share Chart

Zota Health Care Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 80.77

Zota Health Care Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 80.77

NSE:ZOTA vs VRTX, REGN, RVMD: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Zota Health Care's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zota Health Care Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zota Health Care's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Zota Health Care's Cyclically Adjusted PS Ratio falls into.


NSE:ZOTA
79GF Score
Zota Health Care Ltd NSE:ZOTA
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zota Health Care Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zota Health Care's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=47.565/164.2724*164.2724
=47.565

Current CPI (Mar. 2026) = 164.2724.

Zota Health Care Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201203 0.000 76.889 0.000
201303 0.000 85.687 0.000
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201612 0.000 105.196 0.000
201703 6.264 105.196 9.782
201709 0.000 109.021 0.000
201803 0.000 109.786 0.000
201809 0.000 115.142 0.000
201812 8.731 115.142 12.456
201903 8.400 118.202 11.674
201906 8.880 120.880 12.068
201909 10.201 123.175 13.605
201912 9.891 126.235 12.871
202003 9.313 124.705 12.268
202006 7.219 127.000 9.338
202009 11.354 130.118 14.334
202012 12.400 130.889 15.563
202103 12.739 131.771 15.881
202106 13.614 134.084 16.679
202109 14.321 135.847 17.318
202112 12.351 138.161 14.685
202203 12.461 138.822 14.746
202206 11.768 142.347 13.581
202209 15.477 144.661 17.575
202212 13.876 145.763 15.638
202303 14.548 146.865 16.272
202306 15.390 150.280 16.823
202309 17.518 151.492 18.996
202312 18.208 152.924 19.559
202403 17.723 153.035 19.024
202406 21.239 155.789 22.396
202409 25.404 157.882 26.432
202412 26.253 158.323 27.240
202503 34.486 157.552 35.957
202506 35.599 159.755 36.606
202509 42.528 162.289 43.048
202512 45.740 163.281 46.018
202603 47.565 164.272 47.565

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹80.77 mean?
Zota Health Care (NSE:ZOTA) has a Cyclically Adjusted Revenue per Share of ₹80.77 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Zota Health Care and its competitors.
Is Zota Health Care's Cyclically Adjusted Revenue per Share too high?
Zota Health Care's current Cyclically Adjusted Revenue per Share is ₹80.77. Overall, Zota Health Care has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zota Health Care's Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
Zota Health Care's Cyclically Adjusted Revenue per Share of ₹80.77 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Zota Health Care and its competitors. Zota Health Care's current Cyclically Adjusted Revenue per Share is ₹80.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zota Health Care stock overvalued right now?
Based on GuruFocus' analysis, Zota Health Care (NSE:ZOTA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,664.08, compared to a current price of ₹1,252.50 — trading 24.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹80.77. Zota Health Care's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Zota Health Care (NSE:ZOTA), the current Cyclically Adjusted Revenue per Share is ₹80.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zota Health Care (NSE:ZOTA) Overvalued in 2026?

Based on GuruFocus' analysis, Zota Health Care stock appears to be undervalued. The current stock price of ₹1,252.50 is trading 24.7% below its estimated GF Value™ of ₹1,664.08. GuruFocus considers Zota Health Care to be Modestly Undervalued.

Key valuation signals for NSE:ZOTA:

  • Cyclically Adjusted Revenue per Share: ₹80.77
  • GF Value™: ₹1,664.08 vs. price of ₹1,252.50 (24.7% below fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the NSE:ZOTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zota Health Care Business Description

Address 2/896, Hira Modi Street, Zota House, Sagrampura, Surat, GJ, IND, 395002
Zota Health Care Ltd is engaged in the manufacturing, trading, and export of pharmaceutical products. The company caters to both domestic and international markets. It offers a vast range of pharmaceutical, nutraceutical, ayurvedic, and OTC products in India and overseas as well.
79GF Score

Get the complete analysis for NSE:ZOTA

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,252.50
Price
₹1,664.08
GF Value